Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Artificially Sweetened Beverages and Alzheimer Risk

Artificially sweetened beverages (with different kinds of sweeteners) could be responsible for increased cerebrovascular risk and close to a 3-fold increase in dementia risk due to Alzheimer’s disease.

Bebidas azucaradas y con edulcorante asociadas a eventos cardiovasculares y mortalidad

Both sweet and artificially sweetened drinks have been associated with cardiometabolic, cerebrovascular and dementia risk. This study prospectively evaluated sweet and sweetened beverage consumption in relation to the events above mentioned in the Framingham community. 

2888 participants over 45 years old were studied to assess the incidence of stroke and 1484 participants over 60 were studied to assess the incidence of dementia. 


Lea también: Bebidas azucaradas y con edulcorante asociadas a eventos cardiovasculares y mortalidad.


The number of drinks was measured using different specific questionnaires bearing in mind both recent and cumulative consumption in the 10-year follow-up. 

After adjusting for age, sex, education (to analyze dementia) calory intake, diet quality, physical activity and tobacco consumption, it was observed that high recent consumption and high cumulative consumption both increased the risk of stroke, any dementia and Alzheimer’s disease. 

When comparing to 0 consumption (as reference) the risk with sweetened beverages was nearly 3 times higher for stroke (HR 2.96 CI 95%, 1.26 to 6.97) and Alzheimer’s (HR 2.89 CI 95%, 1.18 to 7.07). 


Read also: Primary Prevention Guidelines Published for the First Time: Are They Useful for All Patients?


Beverages with natural sugar were not associated to stroke or dementia. 

All this information is contradicting and there are other studies with literally opposite results. The problem is randomizing and, even though multiple adjustments are made, there might be variables out of control. On example could be that the populations at higher risk of events (obesity and diabetes) consume more artificially sweetened beverages and therefore beverages wouldn’t be the cause behind events, but the baseline risk of this population. 

Original Title: Sugar- and Artificially Sweetened Beverages and the Risks of Incident Stroke and Dementia. A Prospective Cohort Study.

Reference: Matthew P. Pase et al. Stroke. 2017;48:1139-1146.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | P2Y12 Inhibitor Monotherapy After Complex PCI in ACS: Results From the NEO-MINDSET COMPLEX Subanalysis

This is a summary of the NEO-MINDSET COMPLEX subanalysis, presented by Dr. Guy Prado at EuroPCR 2026, which evaluated P2Y12 inhibitor monotherapy versus dual...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

EuroPCR 2026 | Could clopidogrel replace aspirin as monotherapy after PCI?

This presentation, delivered during EuroPCR 2026, analyzed the clinical outcomes of clopidogrel monotherapy versus aspirin in patients who remained event-free for 12 months after...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...